News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
343,514 Results
Type
Article (12570)
Company Profile (22)
Press Release (330922)
Section
Business (137404)
Career Advice (787)
Deals (25299)
Drug Delivery (41)
Drug Development (34378)
Employer Resources (49)
FDA (6136)
Job Trends (7276)
News (201961)
Policy (13943)
Tag
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Pharm Country Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (643)
Accelerated approval (3)
Adcomms (3)
Allergies (30)
Alliances (20576)
ALS (28)
Alzheimer's disease (611)
Antibody-drug conjugate (ADC) (44)
Approvals (6174)
Artificial intelligence (72)
Autoimmune disease (10)
Automation (7)
Bankruptcy (275)
Best Places to Work (6097)
BIOSECURE Act (12)
Biosimilars (47)
Biotechnology (20)
Bladder cancer (28)
Brain cancer (14)
Breast cancer (107)
Cancer (927)
Cardiovascular disease (66)
Career advice (683)
Career pathing (14)
CAR-T (52)
Cell therapy (186)
Cervical cancer (10)
Clinical research (28778)
Collaboration (300)
Compensation (96)
Complete response letters (8)
COVID-19 (871)
CRISPR (15)
C-suite (110)
Cystic fibrosis (37)
Data (998)
Denatured (3)
Depression (19)
Diabetes (95)
Diagnostics (3029)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (41)
Drug pricing (36)
Drug shortages (4)
Duchenne muscular dystrophy (44)
Earnings (84507)
Editorial (12)
Employer branding (5)
Employer resources (45)
Events (46515)
Executive appointments (386)
FDA (6681)
Featured Employer (12)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (520)
Gene editing (42)
Generative AI (7)
Gene therapy (129)
GLP-1 (291)
Government (1435)
Grass and pollen (1)
Guidances (40)
Healthcare (8967)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (43)
Indications (12)
Infectious disease (925)
Inflammatory bowel disease (61)
Inflation Reduction Act (5)
Influenza (23)
Intellectual property (41)
Interviews (154)
IPO (13604)
IRA (18)
Job creations (1442)
Job search strategy (575)
Kidney cancer (5)
Labor market (9)
Layoffs (248)
Leadership (5)
Legal (3515)
Liver cancer (38)
Lung cancer (125)
Lymphoma (59)
Management (20)
Manufacturing (119)
MASH (41)
Medical device (7132)
Medtech (7133)
Mergers & acquisitions (12080)
Metabolic disorders (269)
Multiple sclerosis (36)
NASH (7)
Neurodegenerative disease (27)
Neuropsychiatric disorders (7)
Neuroscience (800)
NextGen: Class of 2025 (3288)
Non-profit (1279)
Northern California (1276)
Now hiring (4)
Obesity (127)
Opinion (133)
Ovarian cancer (39)
Pain (37)
Pancreatic cancer (49)
Parkinson's disease (44)
Partnered (9)
Patents (98)
Patient recruitment (36)
Peanut (16)
People (28361)
Pharmaceutical (6)
Pharmacy benefit managers (5)
Phase I (8478)
Phase II (13022)
Phase III (10225)
Pipeline (837)
Podcasts (38)
Policy (57)
Postmarket research (718)
Preclinical (3113)
Press Release (11)
Prostate cancer (44)
Psychedelics (9)
Radiopharmaceuticals (146)
Rare diseases (148)
Real estate (1897)
Recruiting (17)
Regulatory (9851)
Reports (17)
Research institute (615)
Resumes & cover letters (84)
Rett syndrome (4)
RNA editing (3)
RSV (13)
Schizophrenia (31)
Series A (106)
Series B (76)
Service/supplier (2)
Sickle cell disease (25)
Southern California (1258)
Special edition (6)
Spinal muscular atrophy (69)
Sponsored (10)
Startups (2689)
State (1)
Stomach cancer (4)
Supply chain (20)
The Weekly (34)
United States (12053)
Vaccines (265)
Venture capitalists (22)
Webinars (6)
Weight loss (68)
Women's health (9)
Worklife (4)
Date
Today (72)
Last 7 days (443)
Last 30 days (1723)
Last 365 days (19119)
2025 (4861)
2024 (19952)
2023 (23105)
2022 (27685)
2021 (29563)
2020 (28183)
2019 (22282)
2018 (16996)
2017 (17908)
2016 (15451)
2015 (19192)
2014 (14400)
2013 (11553)
2012 (12250)
2011 (12477)
2010 (11761)
Location
Africa (291)
Alabama (25)
Alaska (3)
Arizona (91)
Arkansas (5)
Asia (18907)
Australia (2929)
California (3049)
Canada (1139)
China (162)
Colorado (150)
Connecticut (158)
Delaware (56)
Europe (42786)
Florida (561)
Georgia (125)
Idaho (20)
Illinois (258)
India (8)
Indiana (156)
Iowa (3)
Japan (74)
Kansas (42)
Kentucky (6)
Louisiana (5)
Maine (56)
Maryland (441)
Massachusetts (2067)
Michigan (159)
Minnesota (204)
Mississippi (2)
Missouri (54)
Montana (14)
Nebraska (6)
Nevada (43)
New Hampshire (36)
New Jersey (1029)
New Mexico (6)
New York (1017)
North Carolina (566)
North Dakota (2)
Northern California (1276)
Ohio (95)
Oklahoma (3)
Oregon (6)
Pennsylvania (720)
Puerto Rico (8)
Rhode Island (15)
South America (489)
South Carolina (12)
South Dakota (1)
Southern California (1258)
Tennessee (52)
Texas (475)
Utah (99)
Virginia (69)
Washington D.C. (34)
Washington State (352)
West Virginia (3)
Wisconsin (22)
343,514 Results for "fina biosolutions llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development
October 29, 2024
·
3 min read
Lone Star Bio
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization, for the production of an E.coli-expressed CRM197 conjugate vaccine carrier protein.
July 27, 2023
·
3 min read
Press Releases
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
41 min read
Press Releases
Emergent BioSolutions Announces Stock Repurchase Program
April 1, 2025
·
3 min read
Press Releases
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 19, 2025
·
1 min read
Press Releases
Afton Scientific, LLC Announces the Appointment of Jason Spacek and Jesse Boyd as Chief Commercial Officer and Chief Financial Officer
March 27, 2025
·
1 min read
Press Releases
Artis BioSolutions Emerges from Stealth, Announces Acquisition of Landmark Bio
April 2, 2025
·
5 min read
Press Releases
Landmark Bio Acquired by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies
April 2, 2025
·
3 min read
Press Releases
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
March 10, 2025
·
4 min read
Press Releases
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
March 21, 2025
·
1 min read
1 of 34,352
Next
